Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daylight vs Conventional PDT for Acne Vulgaris
NCT04631250Completed
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Nov 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of 5-aminolevulinic acid in acne vulgaris (2 arms), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoints: Reduction in acne lesion counts, Reduction in total acne severity score and 1 more. Started Nov 2018; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04631250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04631250.